BACKGROUND: The mechanisms underlying body weight evolution after diet-induced weight loss are poorly understood. OBJECTIVE: We aimed to identify and characterize differences in the subcutaneous adipose tissue (SAT) transcriptome of subjects with different weight changes after energy restriction-induced weight loss during 6 mo on 4 different diets. DESIGN: After an 8-wk low-calorie diet (800 kcal/d), we randomly assigned weight-reduced obese subjects from 8 European countries to receive 4 diets that differed in protein and glycemic index content. In addition to anthropometric and plasma markers, SAT biopsies were taken at the beginning [clinical investigation day (CID) 2] and end (CID3) of the weight follow-up period. Microarray analysis was used to define SAT gene expression profiles at CID2 and CID3 in 22 women with continued weight loss (successful group) and in 22 women with weight regain (unsuccessful group) across the 4 dietary arms. RESULTS: Differences in SAT gene expression patterns between successful and unsuccessful groups were mainly due to weight variations rather than to differences in dietary macronutrient content. An analysis of covariance with total energy intake as a covariate identified 1338 differentially expressed genes. Cellular growth and proliferation, cell death, cellular function, and maintenance were the main biological processes represented in SAT from subjects who regained weight. Mitochondrial oxidative phosphorylation was the major pattern associated with continued weight loss. CONCLUSIONS: The ability to control body weight loss independent of energy intake or diet composition is reflected in the SAT transcriptome. Although cell proliferation may be detrimental, a greater mitochondrial energy gene expression is suggested as being beneficial for weight control. This trial was registered at clinicaltrials.gov as NCT00390637.
RCT Entities:
BACKGROUND: The mechanisms underlying body weight evolution after diet-induced weight loss are poorly understood. OBJECTIVE: We aimed to identify and characterize differences in the subcutaneous adipose tissue (SAT) transcriptome of subjects with different weight changes after energy restriction-induced weight loss during 6 mo on 4 different diets. DESIGN: After an 8-wk low-calorie diet (800 kcal/d), we randomly assigned weight-reduced obese subjects from 8 European countries to receive 4 diets that differed in protein and glycemic index content. In addition to anthropometric and plasma markers, SAT biopsies were taken at the beginning [clinical investigation day (CID) 2] and end (CID3) of the weight follow-up period. Microarray analysis was used to define SAT gene expression profiles at CID2 and CID3 in 22 women with continued weight loss (successful group) and in 22 women with weight regain (unsuccessful group) across the 4 dietary arms. RESULTS: Differences in SAT gene expression patterns between successful and unsuccessful groups were mainly due to weight variations rather than to differences in dietary macronutrient content. An analysis of covariance with total energy intake as a covariate identified 1338 differentially expressed genes. Cellular growth and proliferation, cell death, cellular function, and maintenance were the main biological processes represented in SAT from subjects who regained weight. Mitochondrial oxidative phosphorylation was the major pattern associated with continued weight loss. CONCLUSIONS: The ability to control body weight loss independent of energy intake or diet composition is reflected in the SAT transcriptome. Although cell proliferation may be detrimental, a greater mitochondrial energy gene expression is suggested as being beneficial for weight control. This trial was registered at clinicaltrials.gov as NCT00390637.
Authors: Kelvin H M Kwok; Mikael Rydén; Daniel P Andersson; Gallic Beauchef; Christelle Guere; Katell Vie; Otto Bergman; Veroniqa Lundbäck; Peter Arner; Ingrid Dahlman Journal: Int J Obes (Lond) Date: 2019-06-04 Impact factor: 5.095
Authors: R Jokinen; R Rinnankoski-Tuikka; S Kaye; L Saarinen; S Heinonen; M Myöhänen; E Rappou; S Jukarainen; A Rissanen; A Pessia; V Velagapudi; K A Virtanen; E Pirinen; K H Pietiläinen Journal: Int J Obes (Lond) Date: 2017-12-05 Impact factor: 5.095
Authors: N J T Roumans; R G Vink; F G Bouwman; P Fazelzadeh; M A van Baak; E C M Mariman Journal: Int J Obes (Lond) Date: 2016-12-05 Impact factor: 5.095
Authors: M Kunešová; P Hlavatý; E Tvrzická; B Staňková; P Kalousková; N Viguerie; T M Larsen; M A van Baak; S A Jebb; J A Martinez; A F H Pfeiffer; A Kafatos; T Handjieva-Darlenska; M Hill; D Langin; A Zák; A Astrup; W H M Saris Journal: Physiol Res Date: 2012-10-25 Impact factor: 1.881
Authors: Donia Macartney-Coxson; Kirsty Danielson; Jane Clapham; Miles C Benton; Alice Johnston; Angela Jones; Odette Shaw; Ronald D Hagan; Eric P Hoffman; Mark Hayes; Jacquie Harper; Michael A Langston; Richard S Stubbs Journal: Obesity (Silver Spring) Date: 2020-03 Impact factor: 5.002
Authors: A Besse-Patin; E Montastier; C Vinel; I Castan-Laurell; K Louche; C Dray; D Daviaud; L Mir; M-A Marques; C Thalamas; P Valet; D Langin; C Moro; N Viguerie Journal: Int J Obes (Lond) Date: 2013-08-27 Impact factor: 5.095
Authors: M M J van Greevenbroek; S Ghosh; C J H van der Kallen; M C G J Brouwers; C G Schalkwijk; C D A Stehouwer Journal: J Clin Endocrinol Metab Date: 2012-10-09 Impact factor: 5.958